SMTL ID : 3d68.1 (2 other biounits)

Crystal structure of a T325I/T329I/H333Y/H335Q mutant of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI-IIYQ)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 2 residues within 4Å: Chain A: V.42, N.45 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.45 NAG.2: 4 residues within 4Å: Chain A: E.51, N.74, A.75, S.76 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.74, A:S.76 NAG.3: 1 residues within 4Å: Chain A: N.86 No protein-ligand interaction detected (PLIP) NAG.4: 2 residues within 4Å: Chain A: N.109, E.399 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.109

1 x ZN: ZINC ION(Non-covalent)

ZN.5: 4 residues within 4Å: Chain A: H.182, E.185, H.311 Ligands: ARG.6 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.182, A:E.185, A:E.185, A:H.311

1 x ARG: ARGININE(Non-covalent)

ARG.6: 13 residues within 4Å: Chain A: H.182, R.240, N.257, R.258, H.311, S.322, L.363, Y.364, A.366, D.371, T.384, E.386 Ligands: ZN.5 14 PLIP interactions: 13 interactions with chain A, 1 Ligand-Ligand interactions Hydrophobic interactions: A:T.384 Hydrogen bonds: A:N.257, A:S.322, A:Y.364, A:A.366, A:T.384, A:E.386 Salt bridges: A:H.182, A:R.240, A:R.258, A:H.311, A:D.371, A:D.372, R.6

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Marx, P.F. et al., Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation. Blood (2008)

Release Date

2008-07-01

Peptides

Carboxypeptidase B2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carboxypeptidase B2

Related Entries With Identical Sequence